Back to search

Indoor Biotechnologies Limited

02887403

active
Private Limited Company
england wales
Companies House
Health Score
74 / 100

Some Concerns

30/30
Filing
10/30
Financial
34/40
Risk
  • Current liabilities exceed current assets (-10)
  • 3 outstanding charges (-6)

Details

114-120 NORTHGATE STREET, CHESTER, CH1 2HT
Incorporated 13/01/1994

Compliance

Last accounts

31/12/2025

total exemption full

Next accounts due

30/09/2027

On track

Confirmation statement

Last: 20/05/2025

Due 03/06/2026

On track

Industry

72110
Research and experimental development on biotechnology
72190
Other research and experimental development on natural sciences and engineering

Officers

Dr Martin Dudley Chapman

director · Since 17/06/1994

CORPORATE EXECUTIVE

BRITISH · UNITED KINGDOM · Age 71

Madeleine Cicely Watkins

director · Since 17/06/1994

GRAPHIC DESIGNER

BRITISH · UNITED KINGDOM · Age 72

Persons with Significant Control

Dr Martin Dudley Chapman

25–50% shares
25–50% votes

British · United States · Age 71

114-120, Northgate Street, Chester, CH1 2HT

Notified 01/07/2016

Mrs Madeleine Cicely Watkins

25–50% shares
25–50% votes

British · United States · Age 72

114-120, Northgate Street, Chester, CH1 2HT

Notified 31/12/2024

Former PSCs

Mrs Madeleine Cicely Watkins

Ceased 01/01/2021

Inbio Holdings, Llc

Ceased 31/12/2024

Charges3 outstanding

Charge
outstanding

LLOYDS BANK PLC

Created 12/02/2025Registered 12/02/2025
Charge
outstanding

LLOYDS BANK PLC

Created 12/02/2025Registered 12/02/2025
Charge
outstanding

LLOYDS BANK PLC

Created 02/10/2020Registered 14/10/2020

CompanyRankvs 17+ SIC 72110 peers
78

Financial strength95th percentile among SIC peers · 24/25
Employees92th percentile among SIC peers · 14/15
LiquidityCurrent ratio 7.65× · 20/20
Longevity15 years trading (max 15) · 15/15
Filing complianceAll filings up to date · 15/15
Outstanding charges -10
Show leaderboard
1Werfen Limited
90
2Biopharma Process Systems Limited
90
3Theradex (Europe) Limited
90
4Spicer Consulting Limited
90
5Exmoor Pharma Concepts Limited
90
6Ubc Late Stage (Uk) Limited
90
7Wuxi Apptec Uk Ltd
90
8Bio - Diagnostics Limited
89
9Biointeractions Limited
89
10Ams Advanced Medical Services Limited
89
17Indoor Biotechnologies Limited
88
How is this score calculated?
Financial strength24/25 pts

Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.

Employees14/15 pts

Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.

Liquidity20/20 pts

Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.

Longevity15/15 pts

One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.

Filing compliance15/15 pts

Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.

Risk deductions

Outstanding charges: -10 pts

Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.

Key FinancialsYear ending 31/12/2025

Net Worth

£2.0M

Balance sheet strength

Cash

£1.1M

Cash in the bank

Net Current Assets

£1.9M

Working capital

Current Assets

£2.2M

Current Liabilities

£284k

Fixed Assets

£167k

Debtors

£506k

10avg. employees+1

Balance Sheet

Intangible assets£13k
Assets less current liabilities£2.1M
Prepared with IRIS Accounts Production

EstimatesDerived

YearCurrent RatioImplied Profit
20257.65+£102k
20245.73+£31k
20233.19+£267k
20222.33+£30k
20212.97+£68k
20202.74+£156k
20193.98-£78k
20183.44—

Derived from filed accounts. Not audited figures.